MCP-1 is closely related to inflammation and fibrosis induced by LPS, and is believed to be a good target for treating endotoxemia, sepsis, and peritoneal fibrosis [36], [38], [39]. This evidence concerns the gene CCL2 and Peritoneal Fibrosis.